Bendamustine in the treatment of non-Hodgkin's lymphoma: results and future perspectives.
about
Bendamustine for the treatment of multiple myeloma in first-line and relapsed-refractory settings: a review of clinical trial data.Fludarabine and bendamustine in refractory and relapsed indolent lymphoma--a multicenter phase I/II Trial of the east german society of hematology and oncology (OSHO).Bortezomib in mantle cell lymphoma.Efficacy of rituximab-bendamustine in cold agglutinin haemolytic anaemia refractory to previous chemo-immunotherapy: a case report.
P2860
Bendamustine in the treatment of non-Hodgkin's lymphoma: results and future perspectives.
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Bendamustine in the treatment of non-Hodgkin's lymphoma: results and future perspectives.
@ast
Bendamustine in the treatment of non-Hodgkin's lymphoma: results and future perspectives.
@en
Bendamustine in the treatment of non-Hodgkin's lymphoma: results and future perspectives.
@nl
type
label
Bendamustine in the treatment of non-Hodgkin's lymphoma: results and future perspectives.
@ast
Bendamustine in the treatment of non-Hodgkin's lymphoma: results and future perspectives.
@en
Bendamustine in the treatment of non-Hodgkin's lymphoma: results and future perspectives.
@nl
prefLabel
Bendamustine in the treatment of non-Hodgkin's lymphoma: results and future perspectives.
@ast
Bendamustine in the treatment of non-Hodgkin's lymphoma: results and future perspectives.
@en
Bendamustine in the treatment of non-Hodgkin's lymphoma: results and future perspectives.
@nl
P2093
P356
P1433
P1476
Bendamustine in the treatment of non-Hodgkin's lymphoma: results and future perspectives.
@en
P2093
Dieter Hoelzer
Mathias J Rummel
Paris S Mitrou
P356
10.1053/SONC.2002.34877
P433
4 Suppl 13
P577
2002-08-01T00:00:00Z